The pipetting robot Freedom Evo200 used a customized human BC script where the blood tubes are first barcode-identified then the software converts the location of the BC location into X, Y, Z vectors, which guide the tips of the pipetting arm to dip precisely into the BC layer and to slowly aspirate the BC. Finally the extracted BC (approximately 1ml) is ejected into a separate tube. One BC extraction run for 1-8 samples takes 5 min 20 sec, our configuration of the platform permits to process 24 samples in one run.
Leukocyte content of automatically extracted BCs: Verification
The leukocyte subpopulation content of automatically extracted buffy coats from three adult donors was analysed by flow cytometry (Table 1) . Compared to reference ranges of leukocyte subpopulations in blood of healthy adults (1, 2) , normal values for leukocyte subpopulations (lymphocytes (B-cells and T-cells), monocytes and granulocytes) were detected when BCs were extracted on the Freedom Evo200 platform (natural killer cells were not investigated).
Optimization and efficiency BC is often used for DNA extraction. Quantification of the extracted DNA, from either automatically or manually prepared BCs, permits to assess the efficiency of the BC automation process. Data presented in Table 2 were obtained from 364 healthy volunteer donors over a 6-month timespan during which the BC automation was optimized. The same DNA extraction and quantification protocols were used for all specimens.
BCs were prepared from 8ml blood either automatically or manually, and half of the BC volume was used for DNA extraction, corresponding to an initial 4ml blood volume. The automated BC extraction resulted in a significantly lower DNA yield (47.8 µg) compared to manual BC preparation (61.3 µg). When the whole BC prepared by the Freedom Evo200 was used for DNA extraction, corresponding to 8ml of whole blood, a median DNA yield of 147.9 µg was obtained. Manual BC extraction from 8ml blood resulted in a similar median DNA yield (145.2 µg). Optimization of the BC script for automation resulted in a significantly higher DNA yield (199 µg) when compared to the yields obtained with the previous script. The optimization took into account some specific mechanical parameters of the used tube type. Additionally the settings were optimized to allow a complete aspiration of the BC. As a result, the efficiency of optimized automated BC preparation in terms of DNA yield is higher than in manually prepared BCs.
Validation
To compare the physical content of extracted BCs to whole blood, cell counting was performed on blood before BC extraction and on automatically (optimized script) and manually extracted BCs from the same three donors (Table 3 ). The automatically extracted BCs contained significantly more leukocytes and platelets than the manually prepared BCs. Compared to whole blood, 95% of the blood leukocytes could be recovered in the automatically prepared BCs, whereas in the manually extracted BCs the leukocyte recovery percentage was 56%. Confirmation of these data came from a visual inspection of the collection tubes 30 minutes after the buffy coat extraction, where less buffy coat left-over in the automated tubes was clearly observed (Figure 3 ).
Red blood cell (RBC) contamination in manually or automatically prepared BCs was not significantly different, however in two of the three examined cases, RBC contamination was higher in the manually extracted buffy coats. Haemoglobin values were low both in manually and automatically prepared BCs showing that in general no RBC lysis happened during the BC extraction. The median haemoglobin value was lower in the automatically extracted BCs (in two of the three cases).
In conclusion, the automatically extracted BCs were of high quality presenting high leukocyte and platelets numbers and low red blood cell contamination compared to manually prepared BCs.
In a second part of this experiment the DNA content of the automatically or manually prepared BCs was analysed from the same 3 donors (Table 4 ). The mean DNA yield of 204 g obtained from BC from 8 ml blood (very similar to yields shown in Table 2 ), was 1.5 times higher in the automatically extracted BCs compared to the manually extracted BCs, however the difference was not significantly different due to low numbers of donors. The ratios A260/A280 were high and very stable for both manually and automatically extracted BCs, thus indicating highly pure DNA samples.
Discussion
We demonstrate the feasibility of the BC extraction automation on a Tecan Freedom Evo200 platform. Optimization of the script and validation of the method were based on BC cell content analysis (Blood cell counting and FACS) and on DNA extraction yields. Median DNA yield obtained with the optimized BC script (199 ug DNA from 8ml blood) is significantly higher than the one obtained with the first BC script, highlighting that script optimization was a critical factor for best DNA yield outcomes. The optimized script generated DNA extraction yields which were even significantly higher than the ones from manually prepared BCs (Table 2 and 4). In conclusion, automation of buffy coat extraction permits to isolate all leukocyte subpopulations and to extract high DNA quantities, it eliminates inter-operator variability and is time-saving, since up to 24 samples can be processed at the same time. Besides the Tecan system, Hamilton platforms have also been reported by the manufacturer as being capable of offering automation of buffy coat extraction. In our system, the automated BC extraction can be combined, on one hand, with upstream automated plasma aliquoting in the same run, and downstream automated DNA extraction from BCs on the other hand.
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Population percentages
Reference ranges (healthy adults) automated BC#1 automated BC#2 automated BC#3 Lymphocytes (% leukocytes) 20-44 % (1) 33.9 % 39.4 % 37.1 % Monocytes (% leukocytes) 2-9.5 % (1) 6.5 % 6.7 % 9.8 % Granulocytes (% leukocytes) 42-77 % (1) 59.6 % 53.9 % 53.1 %
CD3 T cells (% lymphocytes)
69-93 % (2) 66.7 % 72.9 % 67.1 %
CD4 T cells (% lymphocytes)
35-72 % (2) 29.7 % 55.3 % 41.8 % CD19 B cells (% lymphocytes) 3-13 % (2) 11.1 % 10.9 % 14.3 % 
